𝔖 Bobbio Scriptorium

✦ LIBER ✦

The stromal reaction in basal cell carcinomas. A prerequisite for tumour progression and treatment strategy

✍ Scribed by U Bertheim; P.Å Hofer; A Engström-Laurent; S Hellström

Book ID: 113495013
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 928 KB
Volume: 57
Category: Article
ISSN: 0007-1226
DOI: 10.1016/j.bjps.2003.12.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

195 Stromal expression of Fer plays as s

195 Stromal expression of Fer plays as suppressor for tumour progression and it was a useful predictor for survival in patients with renal cell carcinoma

✍ Miyata, Y.; Sakai, H.; Greer, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A three-dimensional in vitro tumour inva

A three-dimensional in vitro tumour invasion model for oral squamous cell carcinomas. Evaluation of tumour and stromal cell characteristics and of the extracellular matrix: A. Berndt, P. Hyckel, A. Könneker, H. Kosmehl. (Mund Kiefer GesichtsChir 1998; 2: 256–260)

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 299 KB

PES2 A DECISION-ANALYTIC MODEL TO COMPAR

PES2 A DECISION-ANALYTIC MODEL TO COMPARE THE COST OF METHYL AMINOLEVULINATE PHOTODYNAMIC THERAPY WITH STANDARD TREATMENTS IN THE UK FOR DIFFICULT-TO-TREAT BASAL CELL CARCINOMA AND ACTINIC KERATOSIS

✍ M Aristides; D Tilden; P Robinson; A Weston; P Davey; G Aldridge 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Strategies for assessing and managing th

Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group

✍ Kim Edmonds; Diana Hull; Andrea Spencer-Shaw; José Koldenhof; Maria Chrysou; Chr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 520 KB

A phase III, randomized, open label stud

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma

✍ Thomas K. Eigentler; Anne Kamin; Benjamin M. Weide; Helmut Breuninger; Ulrich M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Randomized phase II/III trial of interfe

Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951): Aass N, De Mulder PHM, Mickisch GHJ, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ, Department of Clinical Cancer Research, The Norwegian Radium Hospital, Oslo, Norway

✍ Robert Flanigan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB